Study incorporated data from over 25,000 patients across 30 sites and compared proactive esophageal cooling to luminal temperature monitoring during RF ablation of the left atrium. CHICAGO--(BUSINESS ...
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent's has enrolled the first patient in the VITAL-EP study. The study is ...
Abbott (NYSE: ABT) today announced new clinical data supporting its minimally invasive therapies for treating AFib.
New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may significantly reduce the risk of atrial fibrillation (AF) returning, offering patients ...
Boston Scientific has announced new data backing its Farapulse pulsed field ablation (PFA) platform for treating AFib.
Please provide your email address to receive an email when new articles are posted on . Advanced electrophysiology fellowship training is essential for operators conducting AF ablations. Complete ...
Enrollment completed ahead of schedule in the global IDE for Abbott (ABT)'s Volt™ PFA System Global FOCALFLEX trial now underway for Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ Advisor™ ...
First Patient Enrolled at Ascension St. Vincent’s in Jacksonville, Florida Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results